Keyphrases
Infant Acute Lymphoblastic Leukemia
100%
Acute Lymphoblastic Leukemia
85%
Leukemia
42%
Mixed-phenotype Acute Leukemia
37%
Acute Lymphoblastic Leukemia Cells
26%
Glucocorticoid Resistance
25%
KMT2A
19%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
19%
MLL4
18%
Childhood Acute Lymphoblastic Leukemia
18%
FMS-like Tyrosine Kinase 3 (FLT3)
16%
Prednisolone
16%
Leukemia Patients
15%
Pediatric
15%
Ara-C
12%
Gene Expression Profile
12%
Prednisone
11%
Myeloid Cell leukemia-1 (Mcl-1)
11%
MLL Fusions
10%
Infant ALL
9%
Histone Deacetylase Inhibitor (HDACi)
9%
Gene Expression
9%
Cord Blood
9%
High-throughput Screening
9%
Leukemic Cells
8%
Central Nervous System Infiltration
8%
KRAS mutation
8%
Decitabine
8%
Methylation
8%
Breast Cancer Resistance Protein
8%
Invasiveness
8%
Vulnerability
8%
Juvenile Myelomonocytic Leukemia
8%
Chemical Genomics
8%
Cas9 Protein
8%
Induced Pluripotent Stem Cells (iPSCs)
8%
Human B Cells
8%
Prognostic Marker
8%
Genome-wide Analysis
8%
MLL-rearranged Leukemia
8%
Acute Myeloid Leukemia
8%
MRNA Expression
7%
MLL Rearrangement
7%
Germ Cells
7%
Gene Signature
7%
Cytarabine
6%
Therapeutic Strategies
6%
Fusion Gene
6%
Hypermethylated
6%
Targeted Therapy
6%
Biochemistry, Genetics and Molecular Biology
B Cell
26%
Glucocorticoid
20%
Gene Expression Profiling
20%
Gene Expression
19%
Prednisolone
16%
Methylation
14%
Promoter Region
13%
Prednisone
11%
Myeloid
10%
Messenger RNA
10%
Transcriptomics
9%
Epigenetics
9%
Cytarabine
9%
KMT2A
9%
DNA Methylation
8%
CRISPR/Cas9
8%
Genome Wide Association Study
8%
Induced Pluripotent Stem Cell
8%
Event Free Survival
8%
Reprogramming
8%
Sensitization
7%
Chimeric Protein
6%
Decitabine
6%
Germ Cell
6%
CpG Island
6%
Fusion Gene
6%
Gene Signature
6%
Mouse Model
6%
Histone Deacetylase
6%
Wild Type
6%
Cancer Cell
5%
Precursor
5%
Enzyme
5%
Germline
5%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
69%
Leukemia
38%
Pediatrics
14%
In Vitro
13%
Leukemia Cell
12%
Glucocorticoid
10%
Acute Myeloid Leukemia
10%
Central Nervous System
9%
Acute B-Cell Lymphoblastic Leukemia
9%
Prednisolone
8%
Genome Wide Association Study
8%
High Throughput Screening
8%
Cord Blood
8%
Xenograft
6%
Disease
5%
Engraftment
5%
Prednisone
5%
Targeted Therapy
5%
